These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 12697975

  • 1. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
    Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J.
    Kidney Blood Press Res; 2003; 26(1):34-41. PubMed ID: 12697975
    [Abstract] [Full Text] [Related]

  • 2. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 3. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J, Linnaluoto M, Peuhkurinen K, Anglo-Scandinavian Cardiac Outcomes Trial Investigators.
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [Abstract] [Full Text] [Related]

  • 4. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G.
    Clin Lab; 2005 Nov; 51(7-8):373-9. PubMed ID: 16122147
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, Tanglay Y, Heinisch C, Reiter M, Drexler B, Arenja N, Twerenbold R, Stolz D, Tamm M, Müller B, Müller C.
    Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
    [Abstract] [Full Text] [Related]

  • 14. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H.
    Am J Med; 2004 Apr 15; 116(8):517-23. PubMed ID: 15063812
    [Abstract] [Full Text] [Related]

  • 15. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F, Mueller C, Breidthardt T, Twerenbold R, Rettig I, Usta E, Häring HU, Friedrich B.
    Kidney Blood Press Res; 2012 Aug 18; 36(1):172-81. PubMed ID: 23108497
    [Abstract] [Full Text] [Related]

  • 17. Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.
    Salo PP, Havulinna AS, Tukiainen T, Raitakari O, Lehtimäki T, Kähönen M, Kettunen J, Männikkö M, Eriksson JG, Jula A, Blankenberg S, Zeller T, Salomaa V, Kristiansson K, Perola M.
    Circ Cardiovasc Genet; 2017 Dec 18; 10(6):e001713. PubMed ID: 29237677
    [Abstract] [Full Text] [Related]

  • 18. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M, Woloszczuk W, Hörl WH.
    Kidney Int; 2000 Jul 18; 58(1):374-83. PubMed ID: 10886584
    [Abstract] [Full Text] [Related]

  • 19. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease.
    Häggström J, Hansson K, Kvart C, Pedersen HD, Vuolteenaho O, Olsson K.
    J Vet Cardiol; 2000 May 18; 2(1):7-16. PubMed ID: 19081325
    [Abstract] [Full Text] [Related]

  • 20. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL, PRAISE-2 study investigators.
    Eur J Heart Fail; 2005 Jun 18; 7(4):557-65. PubMed ID: 15921795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.